Search - tctmd.com

Displaying 201 - 214 of 214

Sort: Relevancy | Date

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

Advertisement

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Evidence Continues to Support Dabigatran Treatment in A-fib

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Poor Association Between Stent Thrombosis, Platelet Function Tests

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content